[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8121 Introduced in House (IH)]

<DOC>






116th CONGRESS
  2d Session
                                H. R. 8121

 To require the Consumer Product Safety Commission to study the effect 
    of the COVID-19 pandemic on injuries and deaths associated with 
               consumer products, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            August 28, 2020

Mr. Cardenas (for himself and Mr. Rodney Davis of Illinois) introduced 
 the following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
 To require the Consumer Product Safety Commission to study the effect 
    of the COVID-19 pandemic on injuries and deaths associated with 
               consumer products, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``COVID-19 Home Safety Act of 2020''.

SEC. 2. REPORT.

    (a) COVID-19 Report Required.--Not later than 3 months after the 
date of the enactment of this section and every 3 months thereafter for 
the duration of the COVID-19 public health emergency, the Consumer 
Product Safety Commission shall submit to the Committee on Energy and 
Commerce of the House of Representatives and the Committee on Commerce, 
Science, and Transportation of the Senate, and make publicly available, 
a report on the effect of the COVID-19 public health emergency on 
injuries and deaths from consumer products.
    (b) Contents of Report.--The report shall include the following:
            (1) Relevant data and statistics from--
                    (A) the data sources of the Commission;
                    (B) other appropriate agencies;
                    (C) media reports;
                    (D) poison control centers, to the extent 
                practical; and
                    (E) any other relevant data sources.
            (2) An identification of trends in injuries and deaths from 
        consumer products, comparing data from representative time 
        periods before and during the COVID-19 public health emergency.
            (3) An identification of subpopulations that have 
        experienced elevated risk of injury or death from consumer 
        products during the COVID-19 public health emergency, such as 
        minorities, infants, people with disabilities, children, or the 
        elderly.
            (4) An identification of where most injuries or deaths from 
        consumer products during the COVID-19 public health emergency 
        are taking place, such as the type of building or outdoor 
        environment.
            (5) A specification about whether consumer products 
        associated with a substantial number of injuries or deaths 
        during the COVID-19 public health emergency are--
                    (A) under recall;
                    (B) subject to a voluntary consumer product safety 
                standard; or
                    (C) subject to a mandatory consumer product safety 
                standard.
            (6) An identification of emerging consumer products that 
        are posing new risks to consumers.
    (c) COVID-19 Public Health Emergency Defined.--The term ``COVID-19 
public health emergency'' means a public health emergency declared 
pursuant to section 319 of the Public Health Service Act (42 U.S.C. 
247d) as a result of confirmed cases of 2019 novel coronavirus (COVID-
19), including any renewal thereof.
                                 <all>